Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia
Infection Control & Hospital Epidemiology · 2025-01 · 46 (1) · 77-80
DOI: 10.1017/ice.2024.182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, online erschienen am 08.11.2024. Verfasst von Clyde D Ford und 5 weiteren Autor:innen. Beteiligte Einrichtung: Intermountain Acute Leukemia Program, LDS Hospital, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Diarrhea, Leukemia, Multiplex Polymerase Chain Reaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Objective
To better delineate multiplexed gastrointestinal polymerase chain reaction (PCR) panel (MGPP) diagnostic and therapeutic stewardship for patients undergoing treatment for acute leukemia including indications and benefits of testing, optimal timing, and interpretation of results. Study design: We retrieved all MGPP ordered on 662 consecutive patients admitted with newly diagnosed acute leukemia between June 2015 and May 2024.
Setting
Regional referral center for acute leukemia.
Results
Fifty-one (17%) of 305 MGPP obtained on the 198 patients who underwent testing identified at least one and 4 (1%) more than one diarrheagenic pathogen. The probability of a positive result was greater if obtained as an outpatient [20/52(38%)], but was not related to type of leukemia, sex, or age. Among the positive results, the pathogens identified included Clostridioides difficile (78% of tests), norovirus (16%), diarrheagenic Escherichia coli (6%), adenovirus 40/41 (4%), and Giardia lamblia (4%). The results of 30 of the 305 tests resulted in a change in treatment (28 C. difficile , 2 G. lamblia ). For the MGPP C. difficile results with an accompanying toxin determination, this included treatment following 16/19 tests with a positive toxin result and 11/19 with a negative. Actionable results other than C. difficile were rarely seen in the inpatient population.
Conclusions
MGPP testing is most useful when administered as an outpatient and of little benefit for inpatients with hospital-onset diarrhea. Since MGPP is sensitive and does not distinguish between colonization and causes of diarrhea, caution is needed in interpretation of results, especially for toxin-negative C. difficile .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Intermountain Acute Leukemia Program, LDS Hospital, Salt Lake City, UT, USA.
- Department of Medicine, Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, UT, USA.
- Department of Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, UT, USA.
- Data Analytics, Intermountain Health, Salt Lake City, UT, USA.
ORCID-Profile: Clyde D Ford, Bradley D Hunter, Jacob Wilkes, Julie Asch, Daanish Hoda
Zitieren
APA
Ford, C. D., Lopansri, B. K., Hunter, B. D., Wilkes, J., Asch, J., & Hoda, D. (2025). Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia. Infection Control & Hospital Epidemiology, 46(1), 77-80. https://doi.org/10.1017/ice.2024.182
Vancouver
Ford CD, Lopansri BK, Hunter BD, Wilkes J, Asch J, Hoda D. Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia. Infection Control & Hospital Epidemiology. 2025;46(1):77-80. doi:10.1017/ice.2024.182
BibTeX
@article{Ford2025,
author = {Ford, Clyde D and Lopansri, Bert K and Hunter, Bradley D and Wilkes, Jacob and Asch, Julie and Hoda, Daanish},
title = {Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
volume = {46},
number = {1},
pages = {77--80},
doi = {10.1017/ice.2024.182}
}
EUVIMED